Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Certain drugs that block specific enzymes can help treat prostate diseases.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Finasteride temporarily lowers male rat fertility without affecting libido.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Bee venom helps hair grow and may work better than some common treatments.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.